Amicus receives FDA approval for Pompe disease therapy
Amicus Therapeutics has received approval from the US FDA for the two-component therapy to treat Pompe disease.
Amicus Therapeutics has received approval from the US FDA for the two-component therapy to treat Pompe disease.
What's Your Reaction?
